These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 20595287

  • 1. Improving the routine management of rheumatoid arthritis: the value of tight control.
    Mease PJ.
    J Rheumatol; 2010 Aug 01; 37(8):1570-8. PubMed ID: 20595287
    [Abstract] [Full Text] [Related]

  • 2. Meta-analysis of tight control strategies in rheumatoid arthritis: protocolized treatment has additional value with respect to the clinical outcome.
    Schipper LG, van Hulst LT, Grol R, van Riel PL, Hulscher ME, Fransen J.
    Rheumatology (Oxford); 2010 Nov 01; 49(11):2154-64. PubMed ID: 20671022
    [Abstract] [Full Text] [Related]

  • 3. Achieving tight control in rheumatoid arthritis.
    van Hulst LT, Hulscher ME, van Riel PL.
    Rheumatology (Oxford); 2011 Oct 01; 50(10):1729-31. PubMed ID: 21933791
    [No Abstract] [Full Text] [Related]

  • 4. Can RAPID3, an index without formal joint counts or laboratory tests, serve to guide rheumatologists in tight control of rheumatoid arthritis in usual clinical care?
    Pincus T.
    Bull NYU Hosp Jt Dis; 2009 Oct 01; 67(3):254-66. PubMed ID: 19852747
    [Abstract] [Full Text] [Related]

  • 5. Assessment and management of rheumatoid arthritis.
    Haraoui B.
    J Rheumatol Suppl; 2009 Jun 01; 82():2-10. PubMed ID: 19509324
    [Abstract] [Full Text] [Related]

  • 6. RAPID3, an index to assess and monitor patients with rheumatoid arthritis, without formal joint counts: similar results to DAS28 and CDAI in clinical trials and clinical care.
    Pincus T, Yazici Y, Bergman MJ.
    Rheum Dis Clin North Am; 2009 Nov 01; 35(4):773-8, viii. PubMed ID: 19962621
    [Abstract] [Full Text] [Related]

  • 7. Patient-driven outcomes in rheumatoid arthritis.
    Wells GA.
    J Rheumatol Suppl; 2009 Jun 01; 82():33-8. PubMed ID: 19509328
    [Abstract] [Full Text] [Related]

  • 8. Determining the minimal clinically important differences in activity, fatigue, and sleep quality in patients with rheumatoid arthritis.
    Wells G, Li T, Maxwell L, MacLean R, Tugwell P.
    J Rheumatol; 2007 Feb 01; 34(2):280-9. PubMed ID: 17304654
    [Abstract] [Full Text] [Related]

  • 9. Remission by composite scores in rheumatoid arthritis: are ankles and feet important?
    Kapral T, Dernoschnig F, Machold KP, Stamm T, Schoels M, Smolen JS, Aletaha D.
    Arthritis Res Ther; 2007 Feb 01; 9(4):R72. PubMed ID: 17662115
    [Abstract] [Full Text] [Related]

  • 10. Assessment of control of rheumatoid arthritis disease activity.
    Salomon-Escoto KI, Gravallese EM, Kay J.
    Best Pract Res Clin Rheumatol; 2011 Aug 01; 25(4):497-507. PubMed ID: 22137920
    [Abstract] [Full Text] [Related]

  • 11. Quality of life and the outcome of established rheumatoid arthritis.
    Kingsley G, Scott IC, Scott DL.
    Best Pract Res Clin Rheumatol; 2011 Aug 01; 25(4):585-606. PubMed ID: 22137926
    [Abstract] [Full Text] [Related]

  • 12. Minimal disease activity, remission, and the long-term outcomes of rheumatoid arthritis.
    Wolfe F, Rasker JJ, Boers M, Wells GA, Michaud K.
    Arthritis Rheum; 2007 Aug 15; 57(6):935-42. PubMed ID: 17665487
    [Abstract] [Full Text] [Related]

  • 13. The overall status in rheumatoid arthritis (OSRA) measure--further evidence to support its use in clinical practice.
    Harrison MJ, Hassell A, Dawes PT, Scott DL, Knight SM, Davis MJ, Mulherin D, Symmons DP.
    Rheumatology (Oxford); 2007 May 15; 46(5):849-55. PubMed ID: 17264089
    [Abstract] [Full Text] [Related]

  • 14. Remission in rheumatoid arthritis: wishful thinking or clinical reality?
    Sesin CA, Bingham CO.
    Semin Arthritis Rheum; 2005 Dec 15; 35(3):185-96. PubMed ID: 16325659
    [Abstract] [Full Text] [Related]

  • 15. Generic quality-of-life assessment in rheumatoid arthritis.
    Tugwell P, Idzerda L, Wells GA.
    Am J Manag Care; 2007 Dec 15; 13 Suppl 9():S224-36. PubMed ID: 18095786
    [Abstract] [Full Text] [Related]

  • 16. How should rheumatoid arthritis disease activity be measured today and in the future in clinical care?
    Sokka T.
    Rheum Dis Clin North Am; 2010 May 15; 36(2):243-57. PubMed ID: 20510232
    [Abstract] [Full Text] [Related]

  • 17. The relationship between social deprivation, disease outcome measures, and response to treatment in patients with stable, long-standing rheumatoid arthritis.
    Harrison MJ, Tricker KJ, Davies L, Hassell A, Dawes P, Scott DL, Knight S, Davis M, Mulherin D, Symmons DP.
    J Rheumatol; 2005 Dec 15; 32(12):2330-6. PubMed ID: 16331758
    [Abstract] [Full Text] [Related]

  • 18. Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study.
    Tsakonas E, Fitzgerald AA, Fitzcharles MA, Cividino A, Thorne JC, M'Seffar A, Joseph L, Bombardier C, Esdaile JM.
    J Rheumatol; 2000 Mar 15; 27(3):623-9. PubMed ID: 10743799
    [Abstract] [Full Text] [Related]

  • 19. Long-term outcomes of rheumatoid arthritis.
    Sokka T.
    Curr Opin Rheumatol; 2009 May 15; 21(3):284-90. PubMed ID: 19342954
    [Abstract] [Full Text] [Related]

  • 20. Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects.
    Hurst S, Kallan MJ, Wolfe FJ, Fries JF, Albert DA.
    J Rheumatol; 2002 Aug 15; 29(8):1639-45. PubMed ID: 12180722
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.